Latest fromPharmac
Pharmac minister, chair refuse to express confidence in CEO Sarah Fitt
The revelation came amid a scrappy start to Parliament's second scrutiny week.
Could Pharmac’s ADHD medication changes be a game-changer or a risk?
A new medicine and simplified renewal criteria for those with ADHD.
More than 6000 ADHD patients to benefit from new drug funding
Pharmac is removing the renewal criteria for stimulant medicine for ADHD and narcolepsy.
'Her legacy': Auckland mum dies as cancer drug is funded
Adrienne Smithson spent her last months fighting for wider access to the medication.
'Huge step forward' for Kiwi women as Pharmac funds new menopause drug
The announcement comes amid a global shortage of transdermal oestrogen patches.
Pharmac minister stops short of supporting law change amid drug-buying reform
A law change was recommended after the first national medicines summit this year.
Opinion: The forgotten cancer – lives at stake as we wait for Govt action
OPINION: More than 21,000 Kiwis are living with a blood cancer.
'Praying for a miracle': Radical step a family could take to keep their mum alive
Maureen King, 69, will soon run out of publicly funded treatment options.
'We all miss him': Mum-of-four on losing husband to blood cancer
Every day eight New Zealanders are diagnosed with a form of blood cancer.
'Life-changing': Cancer 'wonder' drug expected to soon be available for Kiwis
Enhertu has shown 'unprecedented' trial results, giving hope to mums like Maggie Ngatai.
$604 million boost to New Zealand’s drug-buying agency Pharmac
Christopher Luxon announced details of the Government's $604 million boost to the budget of New Zealand’s drug-buying agency Pharmac. Video / Mark Mitchell
Two new cancer drugs to be funded this year
It's expected about 2300 people will have the new drugs funded in the next five years.
Pharmac to fund lifesaving glucose monitors and insulin pumps for type 1 diabetes patients
The funding has been hailed as lifesaving and improving for thousands of Kiwis.
'Cruellest twist of fate': Kiwi scientist diagnosed with same cancer she was researching
'It was shockingly surreal', says Jo Holland.
Seymour plans to tip money into Pharmac and big Pharma
Analysis: Pharmac presents a conundrum for Act Leader David Seymour.
Vaccine for 'devastating disease' expanded to include more at-risk Kiwis
Thousands of immunocompromised Kiwis to benefit from new vaccine funding.
Health NZ backtracks on early free access to 'miracle' cancer drug
Early access to the drug could make a significant difference in some patients' survival.
Health NZ blocks early free access to 'miracle' cancer drug
Early access to the drug could make a significant difference in some patients' survival.
Claire Trevett: Seymour makes the most of his big week as Acting PM
His stint coincided with data drops on benefit numbers and inflation.
Pharmac director quits over Government’s Treaty directive
Pharmac Minister's office says Dr Anthony Jordan has resigned from board.
Audrey Young: Trump shooting and Treaty fights – the political heat is on
OPINION: As Donald Trump's lead extends, NZ has some big foreign policy calls to make.
Te Pāti Māori calls for David Seymour to resign as Associate Health Minister
Comments come after release of Seymour's letter of expectation to Pharmac.
Pharmac called out and speed camera signage | Focus Morning Bulletin July 17, 2024
In today’s headlines with Chereè Kinnear, David Seymour outlines expectations for Pharmac, new speed-camera signage and Tenacious D world tour gets halted.
Minister tells Pharmac to ditch Treaty of Waitangi consideration
Patient advocacy groups are welcoming calls for them to be more involved.
Editorial: National Party's board appointments of the two Bs is a wise choice
OPINION: Paula Bennett and Simon Bridges are a perfect fit.
Grandmother battling cancer told the one drug keeping her alive will no longer be funded
Kiri Carter was given six months, years later she's found out she now has brain cancer.
Cardiac 'crisis' in hospitals, plea for Pharmac to cover heart failure drugs
Heart drugs that add more than eight years of additional life aren't funded.